Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Azelastine hydrochloride (Nasal)
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Azelastine 140micrograms/dose nasal spray
1202010A0AAABAB
|
Azelastine hydrochloride (Nasal) | Azelastine hydrochloride | Ear, Nose and Oropharynx | 16,420 |
|
Azelastine 210micrograms/dose nasal spray
1202010A0AAAEAE
|
Azelastine hydrochloride (Nasal) | Azelastine hydrochloride | Ear, Nose and Oropharynx | 524 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.